| Trial ID: | L0779 |
| Source ID: | NCT00399256
|
| Associated Drug: |
Acetylcysteine
|
| Title: |
Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Failure
|
| Interventions: |
DRUG: Acetylcysteine|DRUG: Zinc
|
| Outcome Measures: |
Primary: Incidence of acute renal failure | Secondary: Rise in creatinine of > 0.5 mg/dl|Rise in creatinine > 25%|Significant rise in serum cystatin C)
|
| Sponsor/Collaborators: |
Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION
|
| Start Date: |
2004-03
|
| Completion Date: |
2006-03
|
| Results First Posted: |
|
| Last Update Posted: |
2007-02-01
|
| Locations: |
Robert-Bosch-Hospital, Stuttgart, D-70376, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00399256
|
